Ken Griffin Organogenesis Holdings Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 10,400 shares of ORGO stock, worth $32,968. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,400
Previous 21,800
52.29%
Holding current value
$32,968
Previous $89,000
67.42%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ORGO
# of Institutions
128Shares Held
59.3MCall Options Held
55.3KPut Options Held
22.2K-
Morgan Stanley New York, NY11.5MShares$36.5 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT9.57MShares$30.3 Million2.22% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$15.8 Million0.0% of portfolio
-
Assenagon Asset Management S.A.3.98MShares$12.6 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.54MShares$11.2 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $415M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...